Ascendis Health Limited (JSE:ASC)

Mark Sardi
Group CEO
Market Cap (AUD): 342.63M
Sector: Health Care
Last Trade (AUD): 0.7 +0 (+0%)
Tab Bar

1. About

Ascendis Health (JSE:ASC) is a health and wellness company founded in 2008 and listed in the healthcare sector of the JSE in November 2013. In 2015 the Group embarked on an international growth strategy and acquired four businesses in Europe: Farmalider in Spain (2015), Remedica in Cyprus (2016), Scitec in Hungary (2016) and Sunwave Pharma in Romania (2017). Today Ascendis Health has global reach with well known brands and products being sold to more than 120 countries across all continents.


The Group's new strategy is aimed at unifying its ambition as a Group by simplifying its operations and focusing on its core business areas of Pharma and Consumer Healthcare. The Group committed to consistently improving and building its global reach (strongly focused on EMEA) and capabilities in these two areas. Medical and Animal Health are key sectors of its portfolio and the Group will focus on opportunities to strengthen and scale these businesses while improving the returns.

Operating model

The Ascendis Health operating model will change from a geographical structure to a global divisional model comprising Pharma, Consumer Healthcare, Medical and Animal Health. Aligned strategies across the business divisions. will position it more optimally, as a Group, to drive organic growth, create economies of scale and maximise competitive advantages.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk